Home/Filings/4/0002036798-26-000002
4//SEC Filing

ALEXANDER MARGARET A. 4

Accession 0002036798-26-000002

CIK 0001636651other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:55 PM ET

Size

5.5 KB

Accession

0002036798-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-04
ALEXANDER MARGARET A.
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2026-01-04+890,000890,000 total
    Exercise: $1.76Exp: 2036-01-03Common Stock (890,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on January 1, 2027 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0002036798

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:55 PM ET
Size
5.5 KB